Lantto et al. also demonstrated that Sym013, a mixture of monoclonal antibodies targeting EGFR, HER2 and HER3, inhibited proliferation in a large number of cancer cell lines in vitro as well as multiple xenograft models [52]. The gene discussed is EGFR; the disease is cancer.